Bz-L-Arg-OMe*HCl

Bz-L-Arg-OMe*HCl is an L-arginine methyl ester hydrochloride bearing a benzoyl (Bz) N-protecting group, giving a protected amino acid ester with a stereogenic center at the alpha-carbon and a guanidinium-containing side chain. The molecule presents an amide-protected alpha-amino functionality, a methyl ester at the C-terminus, and a guanidine moiety that is typically present as a salt under hydrochloride conditions, which strongly influences solubility and coupling behavior. The combination of N-benzoylation and esterification supports peptide synthesis compatibility while enabling controlled deprotection and side-chain functional manipulation through guanidine-specific chemistry. As a chiral amino acid derivative and peptide building block precursor, Bz-L-Arg-OMe*HCl can be used to construct protected arginine residues and to access downstream intermediates for peptide analogs, biochemical probes, and industrially relevant fine-chemical syntheses.

1. Peptide Synthesis

Bz-L-Arg-OMe*HCl is applied in peptide coupling workflows where a protected arginine residue is required at the growing peptide chain. The Bz group protects the alpha-amino functionality from premature acylation, while the methyl ester at the C-terminus can be converted into activated carboxyl equivalents or transformed into other terminal forms depending on the synthetic sequence. The L-configuration at the alpha-carbon provides stereochemical fidelity for peptide bond formation, and the guanidinium side chain can be managed through salt-state control and subsequent deprotection strategies during peptide assembly. Downstream, this enables preparation of arginine-containing peptides and peptide fragments used in structure-activity relationship studies, biochemical research scaffolds, and peptidomimetic construction.

2. Protected Amino Acid Chemistry

Bz-L-Arg-OMe*HCl is suitable for protected amino acid synthesis planning and protecting-group strategy development in chiral intermediate manufacturing. The benzoyl-protected amine and C-terminal methyl ester define orthogonal functional handles that can be selectively removed or transformed to access free amino acids, carboxylic acids, or alternative ester/acid derivatives. The guanidinium group's salt behavior under hydrochloride conditions can be leveraged to tune solubility during intermediate handling and to support controlled side-chain reactivity in subsequent steps. This structural design supports preparation of arginine-based building blocks for iterative synthesis, including protected fragments used to generate peptide building block libraries and diversified amino acid derivatives.

3. Bioconjugation Chemistry

Bz-L-Arg-OMe*HCl can be employed in chemical biology and bioconjugation pipelines that require arginine-rich motifs or guanidinium-bearing linkers. The guanidine functionality enables strong ionic and hydrogen-bonding interactions that can be exploited when incorporating arginine residues into conjugates, such as peptide tags, affinity ligands, or cell-penetrating motif precursors. The protected alpha-amino and ester groups allow the compound to be processed into coupling-ready intermediates, enabling attachment to biomolecule scaffolds through peptide bond formation or subsequent functional group transformations. Downstream conjugate generation benefits from the stereodefined L-arginine backbone, which helps maintain consistent recognition features in molecular design and analytical characterization.

4. SAR Studies

Bz-L-Arg-OMe*HCl is used in structure-activity relationship studies that require systematic variation of arginine-containing peptide analogs. The protected amino acid ester and N-benzoyl group support sequential assembly of analog series where arginine placement and side-chain context are varied while maintaining controlled protection states during synthesis. The guanidinium side chain can be retained through synthesis and then subjected to deprotection or side-chain-compatible modifications to generate analogs with altered charge distribution and binding properties. Resulting arginine-bearing peptide analogs serve as defined chemical entities for SAR profiling, enabling downstream comparative studies of molecular recognition and interaction patterns in biochemical research settings.

5. Pharmaceutical Intermediate Preparation

Bz-L-Arg-OMe*HCl is relevant to pharmaceutical intermediate preparation where protected arginine derivatives are required as chiral building blocks for peptide-like active ingredients and related intermediates. The Bz-protected alpha-amino group and methyl ester provide a manufacturable protected form that can be integrated into stepwise synthesis routes, including conversion to acid derivatives for coupling or further functional transformations. The hydrochloride salt form supports handling and can influence crystallization and downstream processing behavior in fine chemical manufacturing contexts. This makes the compound suitable for producing arginine-containing intermediates that feed into peptide synthesis, peptidomimetic construction, and industrial-scale preparation of defined chiral fragments for applied product development.

6. Process Chemistry Intermediate

Bz-L-Arg-OMe*HCl can be applied as a process chemistry intermediate for industrial chemical manufacturing routes targeting amino acid derivative supply. The combination of a stable N-protection group (benzoyl) and a C-terminal ester (methyl ester) creates a controlled reactivity profile that supports predictable transformations during intermediate staging and purification. The L-configuration and guanidinium salt-state behavior can be managed to maintain stereochemical integrity and consistent material properties across synthetic batches. Downstream, the compound can be converted into other protected arginine forms or into coupling-ready derivatives, supporting scalable production of protected amino acid building blocks used in peptide science, specialty chemical production, and industrial biocatalysis-adjacent workflows.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII